Non-Invasive Prenatal Testing Market: Introduction
Transparency Market Research has
published a new report titled ‘Global Non-Invasive Prenatal Testing Market’.
According to the report, the global non-invasive
prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The
global non-invasive prenatal testing market is expected to expand at a CAGR of
16.4% during the forecast period from 2019 to 2027.
Overview
·
Rise in prevalence of chronic conditions, such
as cancer and diabetes, has increased the patient pool, followed by rise in
demand for biologic drugs for treating various chronic conditions, resulting in
boosting the growth of the Non-Invasive Prenatal Testing market
·
The market is anticipated to witness strong
growth from 2019 to 2027. Increasing demand for early and non-invasive
procedures is also considered as a major factor driving the NIPT market
globally. For pregnant women at high risk of fetal chromosomal abnormalities
(women aged 35 years and older, personal or family history of aneuploidy and
positive result with conventional screening method), making a decision at early
stage is very important, as a delay may lead to unnecessary pain and discomfort
along with developmental issues with the fetus.
Request a PDF
Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=374
·
Rising demand for early screening is projected
to trigger the demand for NIPTs globally, as most NIPTs available in the market
can be recommended as early as 9 weeks to 10 weeks of gestation. Traditional
invasive prenatal testing, such as amniocentesis and chronic villus sampling
(CVS), are associated with the risk of miscarriage. On account of the fact that
NIPTs completely eliminate the risk of miscarriage, they are being increasingly
preferred by women over invasive prenatal testing.
·
Globally, the average age of first-time mothers
is increasing, especially in developed countries such as U.S., U.K., France,
Germany, Italy, and Japan. Financial stability, rising literacy rates, and
social factors are key factors responsible for the advancing maternal age. The
risk of fetal chromosomal aneuploidies is directly related to the rise in
maternal age.
·
Increasing maternal age and advantages of NIPT
over traditional invasive testing are some of the factors responsible for
driving the market growth
Request for Custom
Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=374
Materni21 Test Type Segment to Dominate Global Market
·
Based on test type, the MaterniT21 segment
accounted for major share of the global non-invasive prenatal testing market in
2018.
·
Dominance of the segment in the global market is
attributable to strong brand reputation of MaterniT21 and acquisition of
Sequenom by Labcorp.
·
In the U.S, Sequenom (which is presently a part
of Labcorp) introduced MateriT21 in 2011, which was the first NIPT solution in
the U.S. MaterniT21 is able to identify trisomies and expanded tests may also
explain sex chromosomes disabilities and some microdeletions. Less percentage
error is a significant advantage of MaterniT21. In addition to MaterniT21, the
panorama segment held a notable share of the market, in terms of volume, in
2018.
Request for Analysis
of COVID19 Impact on Non-Invasive Prenatal Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=374
Trisomy Tests to Witness High Adoption During Forecast Period
·
Based on application, the trisomy segment held a
prominent share in 2018 in non-invasive prenatal testing market. The segment is
likely to be highly lucrative during the forecast period.
·
According to the United Nations, the estimated
rate of incidence of Down Syndrome ranges from 1 in 1,000 live births per year
to 1 in 1,100 live births per year. Around 95% cases of Down Syndrome are
nondisjunction cases, whereas translocation and mosaicism cases account for the
rest of 5%.
·
Dominance of the trisomy segment is attributable
to the increasing prevalence of Down Syndrome worldwide and high efficiency of
NIPT for screening of Down Syndrome.
Global Non-Invasive Prenatal Testing Market: Prominent Regions
·
North America held the largest share of the
global Non-Invasive Prenatal Testing market in 2018. North America accounted
for significant share of the global Non-Invasive Prenatal Testing market in
2018. The market in the region is likely to grow at a rapid pace during the
forecast period.
·
The market in the region is driven by presence
of key players, large number of research activities, and highly structured
health care industry
·
Increase in investment by key players in North
America and increasing maternal age are projected to propel the non-invasive
prenatal testing market in North America
·
The U.S. is projected to dominate the
non-invasive prenatal testing market in the region during the forecast period,
owing to early adoption of technologies. The country is anticipated to be the
most attractive market for non-invasive prenatal testing, with high
attractiveness index.
·
Well-equipped hospitals, technological
advancements, rise in research & development in non-invasive prenatal
testing for new applications, and surge in demand for novel products and
treatments are projected to ameliorate the non-invasive prenatal testing market
in the U.S.
Buy Non-Invasive
Prenatal Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=374<ype=S
Global Non-Invasive Prenatal Testing Market: Key Players
·
Players are strengthening their product
portfolio and are collaborating with other companies to secure and strengthen
their positions in the non-invasive prenatal testing market. For instance, in
July 2018, Berry Genetics partnered with 10X Genomics to upgrade non-invasive
DNA prenatal testing. This collaboration was the first step for 10X Genomics to
enter into the market in China.
·
In July 2016, Laboratory Corporation announced
the acquisition of Sequenom for US$ 371 Mn, including debt. With this
acquisition, Laboratory Corporation would strengthen its presence outside the
U.S., in Europe and Asia Pacific, and enable it to provide top quality NIPT
services.
·
Major players operating in the global
Non-Invasive Prenatal Testing market include Berry Genetics, BGI, Laboratory
Corporation of America Holdings, Agilent Technologies, Inc., Illumina, Inc, F.
Hoffmann-La Roche Ltd, NATERA, INC., PerkinElmer Inc, Eurofins LifeCodexx AG,
and IGENOMIX.
More Trending Reports by Transparency Market Research –
Diagnostic Imaging Services Market: http://www.prnewswire.com/news-releases/increasing-adoption-of-new-technology-to-help-diagnostic-imaging-services-market-reach-valuation-worth-us465-bn-by-2027-transparency-market-research-301008184.html
Respiratory Inhaler
Market: https://www.biospace.com/article/respiratory-inhaler-market-approvals-of-various-respiratory-inhaler-products-in-recent-time-is-expected-to-flourish-the-market/
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com/
